Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC
ImmunoHorizons · 2024
DOI: 10.4049/immunohorizons.2400033 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2024. Verfasst von Lavanya Visvabharathy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL. Hauptthemen laut MEDLINE: COVID-19, Autoantibodies, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Patients with long COVID can develop humoral autoimmunity after severe acute SARS-CoV-2 infection. However, whether similar increases in autoantibody responses occur after mild infection and whether vaccination prior to SARS-CoV-2 breakthrough infection can limit autoantibody responses is unknown. In this study, we demonstrate that mild SARS-CoV-2 infection increases autoantibodies associated with rheumatic autoimmune diseases and diabetes in most individuals, regardless of vaccination status prior to infection. However, patients with long COVID and persistent neurologic and fatigue symptoms (neuro-PASC) have substantially higher autoantibody responses than convalescent control subjects at an average of 8 mo postinfection. Furthermore, high titers of systemic lupus erythematosus– and CNS-associated autoantibodies in patients with neuro-PASC are associated with impaired cognitive performance and greater symptom severity. In summary, we found that mild SARS-CoV-2 primary and breakthrough infections can induce persistent humoral autoimmunity in both patients with neuro-PASC and healthy COVID convalescents, suggesting that a reappraisal of mitigation strategies against SARS-CoV-2 is warranted to prevent transmission and potential development of autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
- Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX.
- Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
ORCID-Profile: Lavanya Visvabharathy, Neda Dalil, Chengsong Zhu, Pablo Penaloza-MacMaster, Igor J Koralnik
Förderung
- NIDA NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Visvabharathy, L., Dalil, N., Leonor, L., Zhu, C., Orban, Z. S., Jimenez, M., Lim, P. H., Penaloza-MacMaster, P., & Koralnik, I. J. (2024). Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2400033
Vancouver
Visvabharathy L, Dalil N, Leonor L, Zhu C, Orban ZS, Jimenez M, et al. Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC. ImmunoHorizons. 2024. doi:10.4049/immunohorizons.2400033
BibTeX
@article{Visvabharathy2024,
author = {Visvabharathy, Lavanya and Dalil, Neda and Leonor, Lucia and Zhu, Chengsong and Orban, Zachary S and Jimenez, Millenia and Lim, Patrick H and Penaloza-MacMaster, Pablo and Koralnik, Igor J},
title = {Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC},
journal = {ImmunoHorizons},
year = {2024},
doi = {10.4049/immunohorizons.2400033}
}
EUVIMED